Lachmann N - Search Results

1

Advances in pharmacotherapy to treat kidney transplant rejection.

Bamoulid J, Staeck O, Halleck F, Dürr M, Paliege A, Lachmann N, Brakemeier S, Liefeldt L, Budde K. Bamoulid J, et al. Among authors: lachmann n. Expert Opin Pharmacother. 2015;16(11):1627-48. doi: 10.1517/14656566.2015.1056734. Expert Opin Pharmacother. 2015. PMID: 26159444 Review.

2

Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.

Lachmann N, Terasaki PI, Budde K, Liefeldt L, Kahl A, Reinke P, Pratschke J, Rudolph B, Schmidt D, Salama A, Schönemann C. Lachmann N, et al. Transplantation. 2009 May 27;87(10):1505-13. doi: 10.1097/TP.0b013e3181a44206. Transplantation. 2009. PMID: 19461487

3

Antihumoral rejection therapy by proteasome inhibitor bortezomib: a case series.

Lachmann N, Schütz M, Budde K, Schönemann C, Waiser J. Lachmann N, et al. Clin Transpl. 2009:351-8. Clin Transpl. 2009. PMID: 20527073

4

Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix(®)) in renal transplant recipients.

Brakemeier S, Schweiger B, Lachmann N, Glander P, Schönemann C, Diekmann F, Neumayer HH, Budde K. Brakemeier S, et al. Among authors: lachmann n. Nephrol Dial Transplant. 2012 Jan;27(1):423-8. doi: 10.1093/ndt/gfr278. Epub 2011 May 25. Nephrol Dial Transplant. 2012. PMID: 21613386

5

Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection.

Waiser J, Budde K, Schütz M, Liefeldt L, Rudolph B, Schönemann C, Neumayer HH, Lachmann N. Waiser J, et al. Among authors: lachmann n. Nephrol Dial Transplant. 2012 Mar;27(3):1246-51. doi: 10.1093/ndt/gfr465. Epub 2011 Aug 17. Nephrol Dial Transplant. 2012. PMID: 21852274

6

Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation.

Liefeldt L, Brakemeier S, Glander P, Waiser J, Lachmann N, Schönemann C, Zukunft B, Illigens P, Schmidt D, Wu K, Rudolph B, Neumayer HH, Budde K. Liefeldt L, et al. Among authors: lachmann n. Am J Transplant. 2012 May;12(5):1192-8. doi: 10.1111/j.1600-6143.2011.03961.x. Epub 2012 Feb 2. Am J Transplant. 2012. PMID: 22300538 Free article. Clinical Trial.

7

Identification and therapeutic management of highly sensitized patients undergoing renal transplantation.

Huber L, Lachmann N, Dürr M, Matz M, Liefeldt L, Neumayer HH, Schönemann C, Budde K. Huber L, et al. Among authors: lachmann n. Drugs. 2012 Jul 9;72(10):1335-54. doi: 10.2165/11631110-000000000-00000. Drugs. 2012. PMID: 22747448 Review.

8

Elevation of CD4+ differentiated memory T cells is associated with acute cellular and antibody-mediated rejection after liver transplantation.

Gerlach UA, Vogt K, Schlickeiser S, Meisel C, Streitz M, Kunkel D, Appelt C, Ahrlich S, Lachmann N, Neuhaus P, Pascher A, Sawitzki B. Gerlach UA, et al. Among authors: lachmann n. Transplantation. 2013 Jun 27;95(12):1512-20. doi: 10.1097/TP.0b013e318290de18. Transplantation. 2013. PMID: 23619734

9

Complement-binding anti-HLA antibodies and kidney transplantation.

Baid-Agrawal S, Lachmann N, Budde K. Baid-Agrawal S, et al. Among authors: lachmann n. N Engl J Med. 2014 Jan 2;370(1):84. doi: 10.1056/NEJMc1313506. N Engl J Med. 2014. PMID: 24382077 No abstract available.

10

Pretransplant virtual PRA and long-term outcomes of kidney transplant recipients.

Huber L, Lachmann N, Niemann M, Naik M, Liefeldt L, Glander P, Schmidt D, Halleck F, Waiser J, Brakemeier S, Neumayer HH, Schönemann C, Budde K. Huber L, et al. Among authors: lachmann n. Transpl Int. 2015 Jun;28(6):710-9. doi: 10.1111/tri.12533. Transpl Int. 2015. PMID: 25639331 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page